Mergers & acquisitions
Novartis said the acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace.
The agreement was formally signed yesterday.
SP Industries, Inc., a leading designer and manufacturer of state-of-the-art laboratory equipment, pharmaceutical fill-finish manufacturing solutions, laboratory supplies and glassware, announced that it has acquired the assets of privately held i-Dositecno.
This marks the eighth such extension for the deal.
Edan Diagnostics, Inc., a wholly own subsidiary of Edan Instruments, Inc., a world leader in the development and manufacture of bio-electronic devices and laboratory analyzers for medical diagnostics, and LGC, a global life science tools leader, announced today the sale of LGC’s ClariLight molecular diagnostics POC platform to Edan.
Founder Mike Wenger to Join Staff as Vice President of Patient Engagement
On Thursday, FTC staff reviewing Roche’s $4.8 billion bid for Spark gave the deal a thumbs up after reviewing the potential merger.
The deal is expected to close in the first half of 2020.
Edgewater Capital Partners announced that they have entered into an agreement to acquire Haematologic Technologies Incorporated, a leading provider of biologic products and GMP compliant assay development and testing services to the biopharmaceutical industry.
UCB indicates the deal is part of its strategic growth plan, dubbed the “Accelerate and Expand” phase since 2019.
PRESS RELEASES